Immunotherapy of insulin-dependent diabetes mellitus

Immunotherapy of diabetes is now focusing on induction of tolerance to β cell antigens using either soluble antigens or monoclonal anti-T-cell antibodies. These approaches have reached the clinical arena. At the experimental level, strategies are being developed that use or target cytokines (with gene therapy) or stimulate regulatory T cells.